Asio Capital, LLC Novo Nordisk A S Transaction History

Asio Capital, LLC

  • $507 Million
  • Q3 2024

A detailed history of Asio Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Asio Capital, LLC holds 5,035 shares of NVO stock, worth $534,364. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,035
Previous 5,035 -0.0%
Holding current value
$534,364
Previous $718,000 16.57%
% of portfolio
0.12%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024
SELL
$102.11 - $135.92 $15,827 - $21,067
-155 Reduced 2.99%
5,035 $646,000
Q4 2023

Jan 11, 2024
BUY
$87.78 - $105.45 $41,256 - $49,561
470 Added 9.96%
5,190 $536,000
Q3 2023

Oct 31, 2023
BUY
$90.94 - $199.54 $214,618 - $470,914
2,360 Added 100.0%
4,720 $429,000
Q2 2023

Aug 03, 2023
SELL
$155.98 - $172.65 $31,195 - $34,530
-200 Reduced 7.81%
2,360 $381,000
Q1 2023

Apr 24, 2023
BUY
$132.34 - $159.14 $66,170 - $79,570
500 Added 24.27%
2,560 $407,000
Q3 2022

Oct 27, 2022
SELL
$95.28 - $116.93 $22,867 - $28,063
-240 Reduced 10.43%
2,060 $205,000
Q1 2022

Apr 28, 2022
SELL
$93.1 - $112.54 $9,310 - $11,254
-100 Reduced 4.17%
2,300 $255,000
Q4 2021

Feb 14, 2022
BUY
$95.88 - $117.08 $9,588 - $11,708
100 Added 4.35%
2,400 $269,000
Q3 2021

Nov 01, 2021
BUY
$84.42 - $106.62 $194,166 - $245,226
2,300 New
2,300 $221,000
Q3 2020

Oct 15, 2020
SELL
$63.69 - $70.22 $146,487 - $161,506
-2,300 Closed
0 $0
Q2 2020

Jul 31, 2020
SELL
$58.54 - $67.94 $1,463 - $1,698
-25 Reduced 1.08%
2,300 $151,000
Q1 2020

Apr 28, 2020
SELL
$49.46 - $64.78 $7,419 - $9,717
-150 Reduced 6.06%
2,325 $140,000
Q4 2019

Feb 14, 2020
BUY
$49.86 - $58.26 $123,403 - $144,193
2,475 New
2,475 $143,000

Others Institutions Holding NVO

# of Institutions
1,955
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Asio Capital, LLC Portfolio

Follow Asio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email